Healthy volunteers help test new drug absorption in early-stage trial
NCT ID NCT06749236
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well two different versions of an experimental oral drug (deuterium deuremidevir) are absorbed by the body. It involved 18 healthy Chinese adults aged 18 to 45. Participants took each version once, and researchers measured drug levels in their blood to compare the two. The goal was to gather information for future drug development, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Bengbu Medical College
Xuzhou, Jiangsu, 233004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates